Research into a psychedelic drug used recreationally for decades is showing promise in treating both depression and obsessive-compulsive disorder, according to Yale School of Medicine researchers.
- July 30, 2021Source: Yale News
The COVID-19 pandemic increased our feelings of paranoia, particularly in states where wearing masks was mandated, a new Yale study has shown. That heightened paranoia was particularly acute in states where adherence to mask mandates was low, the researchers report July 27 in the journal Nature Behavior.
- July 30, 2021
João De Aquino, MD, Assistant Professor of Psychiatry, has been selected as a recipient of a travel award for the 2021 American College of Neuropsychopharmacology (ACNP) Annual Meeting.
- July 30, 2021
Telehealth Social Rhythm Therapy to Reduce Mood Symptoms and Suicide Risk Among Adolescents and Young Adults With Bipolar DisorderSource: The American Journal of Psychotherapy
Yale researchers found in a recent study that SRT delivered largely by telemedicine is feasible and acceptable. The intervention appeared to reduce mood symptoms, and suicide propensity independent of mood symptoms, among adolescents and young adults with bipolar disorder.
- July 29, 2021
Angela Haeny, PhD, Assistant Professor of Psychiatry, has been awarded a K23 career development award by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- July 28, 2021
Doximity Poll: Yale Psychiatry Residency Program Ranks #2 in Research, #3 in Reputation For Second Consecutive Year
For the second consecutive year, the Yale Department of Psychiatry Residency Program has ranked second nationally in research and third in reputation in Doximity’s 2021-22 Residency Navigator program, released July 20.
- July 28, 2021Source: Military Times
Morris Bell, PhD, ABPP, Professor Emeritus and Senior Research Scientist in Psychiatry; VA RR&D Senior Research Career Scientist, spoke with Military Times about his recent study that found veterans with a history of mild traumatic brain injury showed vast improvement in cognitive function after 12 weeks using an online brain game program.
- July 27, 2021
Even today, attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations at Yale – Women’s Health Research at Yale (WHRY) and the Office of Cooperative Research (OCR) --- are looking to change those trends, offering grants and programs specifically aimed at supporting women’s health research and supporting women faculty who wish to seek funding to bring their discoveries to a commercial light.
- July 26, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant DepressionSource: Journal of Clinical Psychiatry
Samuel Wilkinson, MD, Assistant Professor of Psychiatry, is co-author of the study, "Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM Studies."
- July 23, 2021Source: JAMA Psychiatry
Hamada Hamid Altalib, DO, MPH, Associate Professor of Neurology and of Psychiatry, is the lead author of a new study comparing the prevalence of suicide attempts among Muslim adults compared with adults of other faith communities in the US. Altalib is part of the Yale Global Mental Health faculty leadership.